Top Markets
Coin of the day
Niki BioSolutions, Inc. Niki BioSolutions, Inc.

Niki BioSolutions, Inc.

NIKI
株式のランク #39003
Niki BioSolutions is a biopharmaceutical company that resulted from the merger... Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
株価
$8.63
時価総額
$702.80K
変化(1日)
3.11%
変化(1年)
-94.09%
US
取引 Niki BioSolutions, Inc. (NIKI)

カテゴリー

Niki BioSolutions, Inc.(NIKI)の配当利回りの履歴
Niki BioSolutions, Inc.(銘柄コード: NIKI)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Niki BioSolutions, Inc.(NIKI)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)